Brookdale Senior Living Inc.
$13.54
▲
0.65%
2026-04-21 05:41:00
www.brookdale.com
NYQ: BKD
Explore Brookdale Senior Living Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$3.2 B
Current Price
$13.54
52W High / Low
$17.09 / $5.79
Stock P/E
—
Book Value
$-0.19
Dividend Yield
—
ROCE
1.61%
ROE
-3.08%
Face Value
—
EPS
$-1.12
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Care Facilities
Employees
22,440
Beta
0.73
Debt / Equity
-123.26
Current Ratio
0.97
Quick Ratio
0.98
Forward P/E
542
Price / Sales
1.06
Enterprise Value
$8.46 B
EV / EBITDA
18.38
EV / Revenue
2.77
Rating
Strong Buy
Target Price
$19.1
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Current ratio suggests tighter short-term liquidity.
- Operating margin is thin.
- Net margin is relatively low.
- Valuation is rich on a P/E basis.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Cross Country Healthcare, Inc. | $9.96 | — | $317.69 M | — | -1.05% | -25.57% | $14.99 / $7.43 | $10.18 |
| 2. | Universal Health Services, Inc. | $180.51 | 7.82 | $11.04 B | 0.45% | 16.23% | 21.33% | $246.32 / $152.33 | $119.15 |
| 3. | Charming Medical Limited | $29.36 | 441.53 | $497.21 M | — | 396.56% | -232.79% | $31.7 / $4.3 | $0 |
| 4. | Chemed Corporation | $385.77 | 19.4 | $5.15 B | 0.62% | 27.27% | 25.28% | $593.8 / $365.2 | $71.44 |
| 5. | Addus HomeCare Corporation | $93.52 | 18.23 | $1.75 B | — | 10.76% | 9.33% | $124.44 / $90.89 | $59.84 |
| 6. | P3 Health Partners Inc. | $2.83 | — | $18.75 M | — | -242.67% | -69.53% | $11.3 / $1.52 | $-47.24 |
| 7. | American Shared Hospital Services | $1.41 | — | $9.46 M | — | -6.29% | -9.45% | $3.11 / $1.25 | $3.65 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 754.09 M | 813.16 M | 812.94 M | 813.86 M | 780.95 M | — |
| Operating Profit | 26.61 M | 13.2 M | 15.44 M | 31.36 M | 3.78 M | — |
| Net Profit | -39.96 M | -114.73 M | -43.02 M | -64.98 M | -83.92 M | — |
| EPS in Rs | -0.17 | -0.48 | -0.18 | -0.27 | -0.35 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 3.19 B | 3.13 B | 3.01 B | 2.74 B |
| Operating Profit | 86.62 M | 55.09 M | 22.69 M | -86.92 M |
| Net Profit | -262.69 M | -201.94 M | -189.01 M | -238.43 M |
| EPS in Rs | -1.1 | -0.85 | -0.79 | -1 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 5.95 B | 6.34 B | 5.57 B | 5.94 B |
| Total Liabilities | 6 B | 6.12 B | 5.17 B | 5.35 B |
| Equity | -44.75 M | 212.47 M | 403.66 M | 582.61 M |
| Current Assets | 553.94 M | 512.94 M | 478.37 M | 637.09 M |
| Current Liabilities | 567.92 M | 579.76 M | 600.12 M | 641.21 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 218.03 M | 166.18 M | 162.92 M | 3.28 M |
| Investing CF | -455.95 M | -278.07 M | -113.36 M | -67.43 M |
| Financing CF | 201.09 M | 142.06 M | -174.44 M | 100.38 M |
| Free CF | 16.5 M | -35.07 M | -70.28 M | -193.64 M |
| Capex | -201.53 M | -201.25 M | -233.21 M | -196.92 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 3.95% | 9.54% | — | — |
| Earnings Growth % | -6.84% | 20.73% | — | — |
| Profit Margin % | -6.46% | -6.29% | -8.69% | — |
| Operating Margin % | 1.76% | 0.75% | -3.17% | — |
| Gross Margin % | 25.57% | 24.53% | 18.72% | — |
| EBITDA Margin % | 13.23% | 13.36% | 11.66% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.